First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum.
Eur J Nucl Med Mol Imaging
; 51(8): 2517-2519, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-38448550
Full text:
1
Database:
MEDLINE
Main subject:
Receptors, Somatostatin
/
Neuroendocrine Tumors
/
Ileal Neoplasms
Limits:
Aged
/
Humans
/
Male
Language:
En
Year:
2024
Type:
Article